Parameter | Group 1 | Group 2 | p Value |
---|---|---|---|
Patients N=87 | Patients N=638 | ||
Aneurysms N=99 | Aneurysms N=749 | ||
Age, mean±SD | 52±14 | 55±14 | 0.0656 |
Women | 58 (65%) | 450 (71%) | 0.4564 |
White | 65 (75%) | 459 (72%) | 0.2476 |
HTN | 58 (67%) | 371 (58%) | 0.1328 |
Smoking | 59 (69%) | 407 (64%) | 0.4038 |
Family history of aneurysms | 13 (15%) | 87 (14%) | 0.7406 |
Primary treatment for SAH | 67 (68%) | 334 (45%) | 1.579E-05 |
Stent assist | 23 (23%) | 261 (35%) | 0.0232 |
Balloon assist | 11 (11%) | 84 (11%) | 1.00 |
Posterior circulation | 25 (25%) | 128 (17%) | 0.0520 |
Glycoprotein IIB/IIIA use | 12 (12%) | 67 (9%) | 0.3554 |
Maximum aneurysm size | 8.28±3.91 | 7.45±4.83 | 0.05 |
Maximum neck size | 4.14±2.28 | 4.06±3.43 | 0.7710 |
SAH, subarachnoid hemorrhage.
Bold type indicates statistically different variables between the two groups.